Similarly, several randomized controlled trials found that oral ergocalciferol or cholecalciferol increased serum 25(OH)D levels among advanced CKD patients and those on hemodialysis without significant alterations in plasma calcium, phosphate, or PTH [22–26]. This evidence concerns the gene PTH and chronic kidney disease.